Ayurvet Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 9.39 Cr
as on 16-11-2024
- Company Age 32 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 50.22 Cr
as on 16-11-2024
- Revenue 2.59%
(FY 2023)
- Profit 30.53%
(FY 2023)
- Ebitda -40.92%
(FY 2023)
- Net Worth -13.90%
(FY 2023)
- Total Assets -11.88%
(FY 2023)
About Ayurvet
- CIN/LLPIN
U74899GJ1992PLC150192
- Company No.
050587
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
12 Oct 1992
- Date of AGM
15 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Ayurvet Limited offer?
Ayurvet Limited offers a wide range of products and services, including Ayurvedic Powder and Medicinal Herbs, Herbs,Sticks and Roots, Fresh, Dried & Preserved Fruits, Fresh Fruits, Fertilizers and Soil Additives, Phosphate Fertilizers, Audio Mixer, Recorder & Transmitter, Audio Devices, Common Disease Medicines, Cough Syrup.
Who are the key members and board of directors at Ayurvet?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nisha Mittal  | CFO | 20-May-2015 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sushil Mehta | Director | Current | |
| Arun Atrey | Director | Current | |
| Vishal Shah | Director | Current |
Financial Performance and Corporate Structure Insights of Ayurvet.
Ayurvet Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.59% increase. The company also saw a substantial improvement in profitability, with a 30.53% increase in profit. The company's net worth observed a substantial decline by a decrease of 13.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ayurvet?
In 2023, Ayurvet had a promoter holding of 97.97% and a public holding of 2.03%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Zenex Animal Health India Private LimitedActive 3 years 9 monthsArun Atrey and Sushil Mehta are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 25 Apr 2022 | ₹4.00 M | Satisfied |
Axis Bank Limited Creation Date: 17 Mar 2018 | ₹7.65 M | Satisfied |
Hdfc Bank Limited Creation Date: 12 Dec 2011 | ₹4.50 Cr | Satisfied |
How Many Employees Work at Ayurvet?
Ayurvet has a workforce of 467 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ayurvet, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ayurvet's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
